Patent · US Active

Process for the depletion or removal of endotoxins

US7510826B2 · kind B2 · utility

3Cited by

14References

4Claims

0Family size

Assignee

QIAGEN GmbH · DE

Inventors

Metin Colpan · Essen, DE
Peter Moritz · Wiesendangen, CH
Joachim Schorr · Düsseldorf, DE

Key dates

Filing date	Apr 27, 2006
Grant date	Mar 31, 2009
Priority date	—
Expiry date	Feb 10, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/10
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

A process for the depletion or removal of endotoxins from preparations containing active ingredients designated for therapeutical use which are obtained from natural sources by genetic engineering and/or biotechnology by treatment with chromatographic material wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.